SM-102

SM-102

SM-102 is a synthetic ionizable lipid which is used in combination with other lipids to form lipid nanoparticles (LNP) for drug delivery. These are used for the delivery of mRNA-based COVID-19 vaccines. The pKa is 6.68. Reagent grade, for research use only.

Molecular structure of the compound BP-25499
    • Unit
    • Price
    • Qty
    • 50 MG
    • $320.00
    • 100 MG
    • $550.00
    • 250 MG
    • $860.00
    • 1 G
    • $1600.00

Usually ships within 24 hours.

Would you like to inquire about custom quantity?
Inquire

Product Citations

  1. Bhattacharya, A., Jan, L., Burlak, O., Li, J., Upadhyay, G., Williams, K., ... & Dey, A. K. (2024). Potent and long-lasting humoral and cellular immunity against varicella zoster virus induced by mRNA-LNP vaccine. npj Vaccines, 9(1), 72.
    https://www.nature.com/articles/s41541-024-00865-5
  2. Binici, B., Rattray, Z., Schroeder, A., & Perrie, Y. (2024). The role of biological sex in pre-clinical (mouse) mRNA vaccine studies. Vaccines, 12(3), 282.
    https://doi.org/10.3390/vaccines12030282
  3. Buckley, M., Arainga, M., Maiorino, L., Pires, I. S., Kim, B. J., Kaczmarek Michaels, K., ... & Irvine, D. J. (2024). Visualizing lipid nanoparticle trafficking for mRNA vaccine delivery in non-human primates. bioRxiv, 2024-06.
    https://doi.org/10.1101/2024.06.21.600088
  4. De Peña, A. C., Zimmer, D., Gutterman-Johns, E., Chen, N. M., Tripathi, A., & Bailey-Hytholt, C. M. (2024). Electrophoretic Microfluidic Characterization of mRNA-and pDNA-Loaded Lipid Nanoparticles. ACS Applied Materials & Interfaces.
    https://pubs.acs.org/doi/abs/10.1021/acsami.4c00208
  5. Jalil, S., Keskinen, T., Juutila, J., Maldonado, R. S., Euro, L., Suomalainen, A., ... & Wartiovaara, K. (2024). Genetic and functional correction of argininosuccinate lyase deficiency using CRISPR adenine base editors. The American Journal of Human Genetics, 111(4), 714-728.
    https://www.cell.com/ajhg/fulltext/S0002-9297(24)00077-6
  6. Meulewaeter, S., Aernout, I., Deprez, J., Engelen, Y., De Velder, M., Franceschini, L., ... & Lentacker, I. (2024). Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria. Journal of Controlled Release, 370, 379-391.
    https://www.sciencedirect.com/science/article/pii/S0168365924002815
  7. Qin, Jane, Ju Hyeong Jeon, Jiangsheng Xu, Laura Katherine Langston, Ramesh Marasini, Stephanie Mou, Brian Montoya et al. Design and preclinical evaluation of a universal SARS-CoV-2 mRNA vaccine. Frontiers in Immunology. 2023
    https://www.researchgate.net/profile/Ramesh-Marasini/publication/369688271_Design_and_preclinical_evaluation_of_a_universal_SARS-CoV-2_mRNA_vaccine/links/642786ee315dfb4ccec16ec4/Design-and-preclinical-evaluation-of-a-universal-SARS-CoV-2-mRNA-vaccine.pdf
  8. Ruppl, A., Kiesewetter, D., Strütt, F., Köll-Weber, M., Süss, R., & Allmendinger, A. (2024). Don’t shake it! Mechanical stress testing of mRNA-lipid nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics, 198, 114265.
    https://www.sciencedirect.com/science/article/pii/S0939641124000912
  9. Saraswat, Aishwarya, and Ketan Patel. Delineating effect of cationic head group and preparation method on transfection versus toxicity of lipid-based nanoparticles for gene delivery. PREPRINT. 2023
    https://www.researchsquare.com/article/rs-2649244/v1
  10. Shah, N., Soma, S. R., Quaye, M. B., Mahmoud, D., Ahmed, S., Malkoochi, A., & Obaid, G. (2024). A Physiochemical, In Vitro, and In Vivo Comparative Analysis of Verteporfin–Lipid Conjugate Formulations: Solid Lipid Nanoparticles and Liposomes. ACS Applied Bio Materials.
    https://pubs.acs.org/doi/full/10.1021/acsabm.4c00316